EP2340872
Nýjar lyfjasamsetningar sem eru gagnlegar við að meðhöndla svefnleysi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
26.10.2005EP published:
5.7.2017EP application number:
11002406.4
EP translation filed:
14.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
25.10.2025Expiry date:
25.10.2023
Title:
New pharmaceutical formulations useful in the treatment of insomnia
Timeline
Today
26.10.2005EP application
5.7.2017EP Publication
14.8.2017Translation submitted
15.9.2017Registration published
25.10.2023Expires
Owner
Name:
Orexo ABAddress:
Box 303, 751 05 Uppsala, SE
Inventor
Name:
Pettersson, AndersAddress:
Kode, SE
Name:
Nyström, ChristerAddress:
Stockholm, SE
Name:
Bredenberg, SusanneAddress:
Uppsala, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0423800Date:
27.10.2004Country:
GB
Classification
Categories:
A61P 25/20, A61K 9/00, A61K 31/44
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 30.10.2017
Expires: 25.10.2018
Payer: Árnason Faktor
Number: 14
Paid: 18.10.2018
Expires: 25.10.2019
Payer: Árnason Faktor
Number: 15
Paid: 25.10.2019
Expires: 25.10.2020
Payer: Tego ehf.
Number: 16
Paid: 22.10.2020
Expires: 25.10.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 27.10.2021
Expires: 25.10.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 27.10.2022
Expires: 25.10.2023
Payer: Árnason Faktor ehf.